Last reviewed · How we verify

NCT03164343

Pain Neuroscience Education in Healthy Children

Completed NA Last updated 5 July 2019
What this trial tests

NA trial testing Pain Neuroscience Education for children in Child in 27 participants. Completed in 22 September 2018.

Timeline
8 August 2017
Primary endpoint
22 September 2018
22 September 2018

Quick facts

Lead sponsorVrije Universiteit Brussel
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment27
Start date8 August 2017
Primary completion22 September 2018
Estimated completion22 September 2018
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Vrije Universiteit Brussel — full company profile →

Who can join

Adults 8 to 12, any sex, with Child or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to examine whether Pain Neuroscience Education for children is able to increase a child's knowledge on the neurophysiology of pain. In addition, this study investigates the influence of PNE on several pain related outcomes; pain-related fear, pain catastrophizing and pain vigilance and awareness.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Do Parental Pain Knowledge, Catastrophizing, and Hypervigilance Improve Following Pain Neuroscience Education in Healthy Children?
    Bacardit Pintó P, Ickmans K, Rheel E, Iwens M, et al · · 2021 · cited 7× · PMID 34065220 · DOI 10.3390/children8050420

Verify or expand the search:

Other recruiting trials for Child

Currently open trials in the same condition.

Other Vrije Universiteit Brussel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03164343.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing